1. Hosseinzadeh S, Jafarikukhdan A, Hosseini A, Armand R. The application of medicinal plants in traditional and modern medicine: a review of Thymus vulgaris. Int J Clin Med. 2015; 6(9): 635-42. [
DOI:10.4236/ijcm.2015.69084]
2. Atanasov AG, Waltenberger B, Pferschy-Wenzig E-M, Linder T, Wawrosch C, Uhrin P,et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol Adv. 2015; 33(8): 1582-614. [
DOI:10.1016/j.biotechadv.2015.08.001] [
PMID] [
PMCID]
3. Ghasemi Pirbalouti A, Koohpayeh A, Karimi I. The wound healing activity of flower extracts of Punica granatum and Achillea kellalensis in Wistar rats. Acta Pol Pharm. 2010; 67(1): 107-10.
4. Shahraki S, Mahdavi S, Hosseini S, Mazandarani M, Tavan M. Investigation quantity and quality of essential oils the Proveskia abrotanoides karel (case study: International park of golestan and kyasar mazandaran). ECO-Phytochem J Med Plant. 2013; 1(3): 68-81.
5. Beikmohammadi M. The evaluation of medicinal properties of Perovskia abrotanoides Karel. Middle-East J Sci Res. 2012; 11(2): 189-93.
6. Kolbady Nejad S, Jaimand K, Monfared A, Akbarzadeh M. Study of the chemical composition of essential oils of Perovskia abrotanoides karel at the different stage and distillation by gas chromatography. JMPB. 2013; 2(2): 139-42.
7. Mahboubi M, Kazempour N. The antimicrobial activity of essential oil from Perovskia abrotanoides karel and its main components. Indian J Pharm Sci. 2009; 71(3): 343-7. [
DOI:10.4103/0250-474X.56016] [
PMID] [
PMCID]
8. Mazandarani M, Ghaemi E. Ethnopharmacological investigation of different parts of Perovskia abrotanoides Karel. Planta Med. 2010; 76(12): 123. [
DOI:10.1055/s-0030-1264421]
9. Morteza-Semnani K. The essential oil composition of Perovskia abrotanoides from Iran. Pharm Biol. 2004; 42(3): 214-6. [
DOI:10.1080/13880200490514078]
10. Sajjadi S, Mehregan I, Khatamsaz M, Asgari G. Chemical composition of the essential oil of Perovskia abrotanoides Karel growing wild in Iran. Flavour Fragr J. 2005; 20(4): 445-6. [
DOI:10.1002/ffj.1508]
11. Moallem SA, Niapour M. Study of embryotoxicity of Perovskia abrotanoides, an adulterant in folk-medicine, during organogenesis in mice. J Ethnopharmacol. 2008; 117(1): 108-14. [
DOI:10.1016/j.jep.2008.01.020] [
PMID]
12. Ashraf SN, Zubair M, Rizwan K, Tareen RB, Rasool N, Zia-Ul-Haq M, et al. Compositional studies and biological activities of Perovskia abrotanoides Karel oils. Biol Res. 2014; 47(1): 12-20.
13. Hosseinzadeh H, Amel S. Antinociceptive effects of the aerial parts of Perovskia abrotanoides extracts in mice. Iran Red Crescent Med J. 2001; 4(1): 15-7.
14. Nasiriasl M, Parvardeh S, Niapour M, Hosseinzadeh H. Antinociceptive and anti-inflammatory effects of Perovskia abrotanoides aerial part extracts in mice and rats. J Med Plants. 2002; 1(3): 1-8.
15. Sairafianpour M, Christensen J, Stærk D, Budnik B, Kharazmi A, Bagherzadeh K, et al. Leishmanicidal, antiplasmodial, and cytotoxic activity of novel diterpenoid 1, 2-quinones from Perovskia abrotanoides: new source of tanshinones. J Nat Prod. 2001; 64(11): 1398-403. [
DOI:10.1021/np010032f] [
PMID]
16. Jaafari MR, Hooshmand S, Samiei A, Hossainzadeh H. Evaluation of-leishmanicidal effect of Perovskia abrotanoides Karel root extract by in vitro leishmanicidal assay using promastigotes of Leishmania major. Pharmacol Online. 2007; 1(1): 299-303.
17. Hashemi S-S, Mahmoodi M, Rafati AR, Manafi F, Mehrabani D. The role of human adult peripheral and umbilical cord blood platelet-rich plasma on proliferation and migration of human skin fibroblasts. World J Plast Surg. 2017; 6(2): 198-205.
18. Hashemi S, Rafati A. Comparison between human cord blood serum and platelet-rich plasma supplementation for human wharton's jelly stem cells and dermal fibroblasts culture.IJMRHS. 2016; 5(8): 191-6
19. Pereira T, Dos Santos D, Lima-Ribeiro MHM, de Pontes-Filho NT, Carneiro-Leão AMdA, Correia MTdS. Development of animal model for studying deep second-degree thermal burns. J Biomed Biotechnol. 2012; 2012(1): 1-7. [
DOI:10.1155/2012/460841] [
PMID] [
PMCID]
20. Abdullahi A, Amini-Nik S, Jeschke M. Animal models in burn research. Cell Mol Life Sci. 2014; 71(17): 3241-55. [
DOI:10.1007/s00018-014-1612-5] [
PMID] [
PMCID]
21. Qu M, Nourbakhsh M. Current experimental models of burns. Discov Med. 2017; 23(125): 95-103.
22. Campelo APBS, Campelo MWS, Britto GAdC, Ayala AP, Guimarães SB, Vasconcelos PRLd. An optimized animal model for partial and total skin thickness burns studies. Acta Cir Bras. 2011; 26(1): 38-42. [
DOI:10.1590/S0102-86502011000700008] [
PMID]
23. Abdeldjelil M, Messai A, Boudebza A, Beghoul S. Practical aspects to generate cutaneous experimental burns in a rat model. Pharm Lett. 2017; 9(1): 70-84.
24. Guo H-F, Ali RM, Hamid RA, Zaini AA, Khaza'ai H. A new model for studying deep partial-thickness burns in rats. Int J Burns Trauma. 2017; 7(6): 107-14.
25. Geryani MA, Mahdian D, Mousavi SH, Hosseini A. Ctotoxic and apoptogenic effects of Perovskia abrotanoides flower extract on MCF-7 and HeLa cell lines. Avic J Phy. 2016; 6(4): 410-7.
26. Nezhadali A, Masrornia M, Solati A, Akbarpour M, Nakai Moghaddam M. Analysis of the flower essential oil at different stages of plant growth and in vitro antibacterial activity of Perovskia abrotanoides Karal in Iran. Der Pharma Chemica. 2009; 1(1): 146-50.